PLP1 and Pelizeaus-Merzbacher spectrum disorder: Genetic testing of PMD is important for affected patients’ families because female carriers with PLP1 duplication will have a male fetus with 50% risk of inherited PMD and a female fetus with 50% risk of carrying PLP1 duplication in any future pregnancies.